Nov. 28, 8:30-10:00 a.m. | S504CD
This session examines important PET/CT findings using FDG and other tracers. Participants also learn how to avoid potential pitfalls, use PET tracers to evaluate tumor response and compare available tracer options for evaluating treatment response.
• Lale Kostakoglu, MD, Mount Sinai Hospital, New York City
• Heather Jacene, MD, Children’s Hospital Boston
• Terence Zekon Wong, MD, PhD, Duke University, Durham, N.C.